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Health policy
The case for psychological treatment centres
Richard Layard
The government is committed to improved access to psychological therapy. How big an expansion is
necessary to meet the NICE guidelines on depression and anxiety, and how should it be organised?
If you have schizophrenia or bipolar depression in
Britain, you will generally get specialist help from the
NHS.1 But only about 1% of the British population
have these terrible conditions. Many more (some 15%
of us) have unipolar depression or anxiety disorders,
yet if you have one of these, often crippling, conditions
you are unlikely to get any specialist help at all. You can
see your general practitioner, but he or she is unlikely
to prescribe any treatment other than drugs.
This pattern of prescribing is completely at
variance with the guidelines from the National Institute
for Health and Clinical Excellence (NICE) on treating
depression and anxiety disorders.2–4 These guidelines
recommend that cognitive behaviour therapy should
be available as an option for all but the mildest or most
recent forms of depression and anxiety. The guidelines
also recommend other forms of psychological therapy
for selected conditions. The guidelines are, of course,
based on hundreds of randomised clinical trials. These
show clearly that cognitive behaviour therapy is as
effective as drugs for treating depression and anxiety in
the short term, and tends to have more durable
effects.2–6 Moreover, psychological help is what
thousands or even millions of patients want.7
At present it is simply impossible for general practi-
tioners to implement the NICE guidelines because the
therapists are not available. Thus mentally ill people are
denied specialist help, whereas it would automatically be
supplied for equally disabling cases of physical illness. If
the NICE guidelines were implemented many more
people would receive help, and massive suffering would
be avoided.And the cost of implementing the guidelines
would be matched by savings to the government in
reduced claims for incapacity benefits.
In what follows I shall discuss the scale of need, and
show that the overall benefits of meeting it exceed the
costs. I shall then show why the expanded provision
should be provided through psychological treatment
centres.
The cost of depression and anxiety
According to theWorld Health Organization, half of all
people with ill health in Western Europe have mental
illness.8–10 It accounts for as much suffering as all physi-
cal illnesses put together. And the bulk of these mental
illnesses are depression and anxiety.
There is also a huge economic cost, because
depression and anxiety make it much more difficult, or
impossible, to do a job. And those capable of working
are likely to have high rates of sickness absence.1 The
resulting loss of output can be calculated as £17bn
(€24bn, $30bn), or 1.5% of UK gross domestic
product.11 Much of this cost falls on the Exchequer,
which loses in consequence roughly £9bn in benefit
payments to mentally ill people and in reduced tax
receipts. There are now more than one million
mentally ill people receiving incapacity benefits—more
than the total number of unemployed people receiving
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unemployment benefits. So in Britain mental illness
has now taken over from unemployment as our great-
est social problem.
Cost effective treatments
Fortunately, much of this suffering and economic
waste can be prevented by new treatments developed
in the past 50 years. The new drug treatments are now
available to all, but the psychological therapies are not:
only 4% of all those with depression and anxiety disor-
ders have received such therapy in the past year.1 Yet,
according to NICE, psychological therapies are at least
as effective as drugs. Many patients do not want to take
drugs but would like “therapy.” This is one of many rea-
sons why only a quarter of all those who are mentally ill
are receiving any form of treatment (including drugs).1
If we are to tackle our mental health problems
effectively, we need to deploy the evidence based
psychological therapies on a large scale.
These therapies are quite different from traditional
psychoanalysis. They are forward looking and practi-
cal, and they typically involve nomore than 16 sessions.
The best developed, and most studied, is cognitive
behaviour therapy, in which patients are taught to
challenge their negative thoughts and to pursue
positive strategies to build on their strengths. A typical
finding for depression (in double blind clinical trials) is
that either drugs or weekly therapy will lift about half of
the treated patients out of depression within four
months. After successful treatment the risk of relapse is
greater for those treated with drugs, unless they keep
on taking them (figure).13–15 Thus the cost effectiveness
of the two approaches is similar, but many people
refuse drugs because of side effects and because they
want to feel more in control of their emotions.
Recovery rates after therapy for anxiety disorders
are similar to those for depression (when weighted by
the types of disorder),2–4 but the benefits are greater
because spontaneous recovery rates are lower. So the
case for wider access to therapy is even more
compelling.
Should the Treasury support psychological
therapy? The cost of therapy would be about £750 for
each patient who embarked on treatment.16 In the next
two years the likely effect, compared with no treatment,
would be about 12 extra months free of illness and at
least one extra month in work, after allowing for natu-
ral recovery that could otherwise occur. In terms of
extra output, the extra time in work is equivalent to
more than £1880, which more than repays the £750
cost of treatment, without including the benefits of
reduced suffering. To value the reduced suffering in
money terms is not easy, but if we assume that a year
free of illness is worth 0.2 QALYs (quality adjusted life
years),17 the extra year without illness is worth about
£6000 (assuming a QALY is “worth” £30 000, in line
with values used by NICE).
Even for the Treasury’s own book-keeping, the
therapy repays its £750 costs through savings on inca-
pacity benefits and higher taxes of around £850 within
two years of treatment. On top of this, there would be
considerable savings to the rest of the NHS. Fewer
people would become so mentally ill that they needed
hospitalisation or outpatient treatment. (In one study,
when cognitive behaviour therapy was made available
to depressed patients via computer, their general prac-
titioners referred 80% fewer people to secondary serv-
ices.18) In addition, fewer people would keep attending
their general practitioners or be sent for counselling.
And fewer people would be referred for supposed
physical illnesses (in London a half of referrals to acute
hospitals failed to reveal a “medically explicable”
physical condition).19
From the available evidence, NICE recommends
cognitive behaviour therapy for every type of disorder,
and various other treatments (such as family therapy
and interpersonal therapy) for a limited range of disor-
ders. While further research will probably show the
wider value of other types of treatment, it seems sensi-
ble to base any proposed expansion of psychological
therapy at this stage predominantly on cognitive
behaviour therapy. This does not mean that the
alternatives should disappear, but a major expansion,
requiring large expenditure, has to be guaranteed to
succeed and must therefore rely on the evidence avail-
able so far. These ideas have received general support
with the British Psychological Society (personal
communication, Graham Turpin, chair of the Division
of Clinical Psychology, British Psychological Society;
see also Roth and Stirling20).
More therapists
So what scale of expansion is needed? It is important
for the government to begin by envisaging what kind
of provision is necessary and justified, and only after
that to consider how fast it could be established. About
2.75 million people go to their general practitioner
with a mental problem during a year. Of these patients,
roughly a third would probably opt for psychological
therapy if it were available (and more would be
encouraged to visit their doctor). Therefore, about
800 000 patients a year would require (mostly)
cognitive behaviour therapy.
If we assume there is one therapist for every 80
patients treated in a year, we need an extra 10 000
therapists. There are two possible sources—clinical
psychologists or a new type of “psychological
therapist.” At present we produce 550 new clinical
psychologists a year; this number should rise sharply,
and most should go into providing therapy—say 5000
extra by 2013. The other 5000 therapists should be
newly trained “psychological therapists” drawn from
mainly older people with experience of mentally ill
people—nurses, occupational therapists, social work-
ers, and counsellors. They should be given rigorous
training in (mostly) cognitive behaviour therapy while
in employment. The “off the job” training would be
part time, and there would be a one year qualification
in cognitive behaviour therapy for a limited range of
conditions and a two year qualification for a wider
range of conditions, including some that are more
complex.
Treatment centres
The final issue is how the work of these therapists
should be organised in order to guarantee its effective-
ness. The answer is: in as similar a way as possible to the
clinical trials that showed it to be effective. This means
that the therapists should work in teams, where junior
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therapists can be properly supervised, motivated,
supported, and trained by senior therapists. Cognitive
behaviour therapy is not like a drug, which is the same
whoever administers it; it is much more effective when
it is more professionally administered.21 So general
practitioners should welcome the opportunity to refer
patients to such teams rather than trying to organise
the therapists themselves. These teams would operate
on a “hub and spoke” basis, with the senior therapists
being based in one building, but the bulk of therapy
being delivered in general practices, job centres, work-
places, voluntary organisations, etc.
The team structure makes it possible for the senior
therapists to make the initial diagnosis and assign the
patient to an appropriate therapist. All therapists
would use a standard one page questionnaire to meas-
ure patient progress, which makes effective monitoring
possible—and, if used nationally, makes it possible to
compare the effectiveness of different teams. The team
structure also allows for more flexible appointments
and for individual therapists to develop particular
areas of expertise. And a central building provides a
location for case conferences, consulting rooms when
these are not otherwise available, and a place to which
patients can self refer when they do not wish to go
through their general practitioner.
The name for these teams should make clear their
connection with the central building, and they might
be called psychological treatment centres (or therapy
centres, if the phrase appeals). The idea of psychologi-
cal treatment centres has received widespread support.
A suitable objective for, say, 2013 would be one
treatment centre for every 250 000 people: the centres
would therefore have much longer spokes in rural than
in urban areas. This would mean roughly 250 centres
altogether in the UK. In rolling out such a system, it is
vital to maintain quality throughout. A sensible
objective could be to roll out 40 new centres each year,
with each centre providing a training ground for future
centres.
The alternative is a more decentralised and locally
varied approach, in which it could be much more diffi-
cult to ensure quality and patient safety: bad therapy
can easily do harm. To achieve a sufficient volume and
quality of therapy will require in the initial phases a
strong lead from the Department of Health.
The fundamental case for expansion is the
evidence that therapy works. This evidence comes from
trials conducted in psychological treatment centres.
The expansion should therefore be provided through
teams based in centres but reaching out to people near
their homes. If this is well done, it could transform the
lives of millions, at no net cost to the Exchequer.
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Summary points
NICE guidelines say that most patients with depression and anxiety
disorders should be offered evidence based psychological therapies
Such treatments yield economic benefits that exceed the cost. There
is no net cost to the government because of savings on incapacity
benefits and other NHS costs
To implement the guidelines requires some 10 000 more therapists.
Training this number is feasible over a seven year period
The extra therapists should work in teams with a central building, but
much of the therapy should be given at “satellite” sites such as
general practices and in job centres. Some 250 of these psychological
treatment centres should be set up over the next seven years
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